Center on Health Equity & Access
See the barriers. Clear the way. Start at the Center on Health Equity & Access.
Highlighting Disparities in Myeloma Outcomes, the Impacts of Comorbidities
The Role of Real-World Data in Advancing Value-Based Cancer Care: CK Wang, MD
Protecting Progress in LGBTQ+ Health Care 10 Years After Obergefell
Self-Administered Subcutaneous Isatuximab May Ease Multiple Myeloma Treatment Burden: Xavier Leleu, MD, PhD
Quality of Life Disparities Persist in R/R Multiple Myeloma Despite Universal Health Care: Francesco Sparano, MSc
Patients With Obesity Face Higher Financial Burden, Food Insecurity
Potential Health Literacy Resources for Health Plans: A Narrative Review
Elimination of Specialists for National Suicide Hotline Removes Important Resource for LGBTQ+ Youth: A Q&A With Hannah Wesolowski
The High Cost of Healthy: How Grocery Prices Shape American Diets and Health
New Findings Highlight Key Role of Clinician Communication in Lymphoma, CLL Care: Lorna Warwick
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Balancing Timing of ASCT: Insights on Delayed Transplantation and Long-Term Treatment Outcomes
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Measuring What Matters: Evidence and End Points That Define Disability in MS
Crossover Study: Nanomicellar Cyclosporine 0.09% vs Emulsion Cyclosporine 0.05%
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Closing Perspectives
SYRUS Study Explores AZD0486 Safety, Dosing in Relapsed/Refractory B-Cell ALL: Ibrahim Aldoss, MD
Ruxolitinib Plus Anemia Supportive Care Maintains Efficacy in Myelofibrosis: Pankit Vachhani, MD
How Transplant, CAR T, and Bispecifics Fit Into Myeloma Care: Mansi Shah, MD
Next Steps for INCA33989 Focus on Dosing, Delivery, and Safety: John Mascarenhas, MD
Supporting Patients and Primary Care Providers
Shifts in Standard of Care for Adults and Children With KMT2A AML
SYRUS Study Explores AZD0486 Safety, Dosing in Relapsed/Refractory B-Cell ALL: Ibrahim Aldoss, MD
Ruxolitinib Plus Anemia Supportive Care Maintains Efficacy in Myelofibrosis: Pankit Vachhani, MD
Next Steps for INCA33989 Focus on Dosing, Delivery, and Safety: John Mascarenhas, MD
Final PICCOLO Data Highlight Efficacy of Mirvetuximab Soravtansine in Later-Line Frα+ Platinum-Sensitive Ovarian Cancer
Potential Health Literacy Resources for Health Plans: A Narrative Review
Population Health Reimagined Through Integrated Care
Moving Evidence From Research to Practice: Q&A With Ken Cohen, MD
Optimizing Advanced Cancer Therapies and Addressing Logistical, Financial Challenges
Value-Based Care Calls for Putting Novel Therapies Closer to Patients
Will Subcutaneous PD-1/PD-L1 Inhibitors Be a Game Changer?
How Value-Based Care With Provider Enablement Improves Maternal and Infant Outcomes in Medicaid
Utilization and Costs Among Oncologists Participating in a Private Insurance Shared Savings Model
Challenges Faced by Medicaid Managed Care Coordinators Working With Members With Substance Use Disorder
Affordable Care Act Enrollment in Texas After Rating Area Adjustments
Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Access, and Adherence
The Changing Paradigm in Pain Management and Supporting Access to Novel Therapies
Integrating Multi-Cancer Early Detection Tests Into Clinical Practice: The Health Economics Perspective for Managed Care Professionals
Addressing the Gaps and Clinical Challenges in Chronic Lymphocytic Leukemia: Updates and Strategies for Managed Care
Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care
Advancing Patient Outcomes in Hidradenitis Suppurativa: Updates and Strategies for Managed Care
The Role of the Specialty Pharmacist in Optimizing Treatment for Amyotrophic Lateral Sclerosis: The Impact of Early Intervention, Patient-Centered Care, and Disease-Modifying Therapies in Slowing Disease Progression
Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmacist Credit)
